Patient With Prolidase Deficiency due to an Homozygous PEPD Variant, Induced by Paternal Uniparental Isodisomy of Chromosome 19
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64125 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Marta Carreño-Hidalgo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Quantitative Genomic Medicine Laboratories (qGenomics), Esplugues de Llobregat, Barcelona, Spain. Hauptthemen laut MEDLINE: Uniparental Disomy, Dipeptidases, Prolidase Deficiency. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ajuts a Doctorats industrials (AGAUR), Agència de Gestió d'Ajuts Universitaris i de Recerca.
Abstract (Originalsprache)
Uniparental disomy (UPD) is a rare phenomenon in which both copies of a chromosome are inherited from a single parent. This can lead to genomic imprinting disorders and recessive disorders due to the presence of recessive pathogenic variants in both alleles. Additionally, depending on the mechanisms by which UPD occurs, mosaic aneuploidies may arise. Here we report the case of a patient with prenatal manifestations of intrauterine growth restriction and polyhydramnios, and postnatal manifestations of multiple congenital anomalies, developmental delay, and facial dysmorphisms. Prenatal exome sequencing targeting the fetal phenotype allowed the detection of uniparental isodisomy of chromosome 19. After birth, exome reanalysis revealed a homozygous pathogenic variant in the PEPD gene. This is the first case of prolidase deficiency due to UPD ever described. Prolidase deficiency is a low‐prevalence disease with significant morbidity and mortality. Early diagnosis is essential to provide prognostic information, design an appropriate interdisciplinary follow‐up program, and anticipate complications. This case highlights the importance of phenotypic assessment and postnatal clinical follow‐up, as well as comprehensive genetic analyses to better understand complex phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Quantitative Genomic Medicine Laboratories (qGenomics), Esplugues de Llobregat, Barcelona, Spain.
- Doctoral Program in Genetics, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
- Medical Genetics Section, Department of Pediatrics, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain.
ORCID-Profile: Marta Carreño-Hidalgo
Förderung
- Ajuts a Doctorats industrials (AGAUR)
- Agència de Gestió d'Ajuts Universitaris i de Recerca
Zitieren
APA
Carreño-Hidalgo, M., Muñoz-Siles, R., López-González, V., Carreño-Gago, L., & Dulcet, L. A. (2025). Patient With Prolidase Deficiency due to an Homozygous PEPD Variant, Induced by Paternal Uniparental Isodisomy of Chromosome 19. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64125
Vancouver
Carreño-Hidalgo M, Muñoz-Siles R, López-González V, Carreño-Gago L, Dulcet LA. Patient With Prolidase Deficiency due to an Homozygous PEPD Variant, Induced by Paternal Uniparental Isodisomy of Chromosome 19. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64125
BibTeX
@article{CarreoHidalgo2025,
author = {Carreño-Hidalgo, Marta and Muñoz-Siles, Raquel and López-González, Vanesa and Carreño-Gago, Lidia and Dulcet, Lluís Armengol},
title = {Patient With Prolidase Deficiency due to an Homozygous PEPD Variant, Induced by Paternal Uniparental Isodisomy of Chromosome 19},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64125}
}
EUVIMED